Health, Nagoya University Graduate School of Medicine-Some animal experiments have shown that mutual metabolic inhibition takes place between nhexane and toluene, but we have found only one report dealing with their metabolic interaction at occupationally relevant exposure levels (Baelum et al. 1998) . In order to evaluate the effect of dose-dependent metabolic interaction between toluene and n-hexane, especially in occupationally relevant exposure conditions such as relevant exposure levels, physical activities and exposure patterns, a physiologically based pharmacokinetic (PBPK) model for co-exposure to nhexane and toluene was developed. The PBPK model for the binary co-exposure was established by initially validating or refining the existing PBPK models for nhexane and toluene and then linking the individual solvent models via the hepatic metabolism terms. In reporting previous findings, noncompetitive inhibition was assumed and the inhibition constant of toluene on n-hexane biotransformation and that of n-hexane on toluene biotransformation used in simulation were 7.5, 30 µm, respectively, in previous data. According to the model, 8 h of constant exposure to 50 ppm nhexane and 25, 50, 100 and 500 ppm toluene will cause about 7%, 18%, 62% and 96% decreases in the urinary excretion of 2,5-hexanedione (2,5-HD) and 4%, 10%, 25% and 30% increases in the n-hexane concentration in blood at the end of the fifth day of exposure simulated in a standard man at a 25 W work load. Simulations of co-exposure to 50 ppm n-hexane and 50 ppm toluene Received June 26, 1998; Accepted Aug 30, 1998 Correspondence to: X. Yu, Department of Occupational and Environmental Health, Nagoya University Graduate School of Medicine, Japan in a standard man who inhaled 50 ppm n-hexane with 0 or 50 ppm toluene for 8 h at different work loads suggest that toluene causes a slight decrease in urinary 2,5-HD in the resting condition, a 17% decrease at 25 W, and a 41% decrease at 50 W work load. The simulations of co-exposure in different exposure patterns with the same time-weighted concentration (TWA) of 50 ppm, i.e. 50 ppm for 8 h, 100 ppm of 4 times for 1 h and 200 ppm of twice for 1 h, showed reductions in urinary 2,5-HD of 17%, 40% and 67%, respectively. These simulations suggest that coexposure to n-hexane and toluene around 50 ppm (TWA) could affect urinary n-hexane metabolites to various degrees depending on the fluctuations in exposure concentrations and variety of work activities in the workplace. (J Occup Health 1998; 40: 293-301) 
in a standard man who inhaled 50 ppm n-hexane with 0 or 50 ppm toluene for 8 h at different work loads suggest that toluene causes a slight decrease in urinary 2,5-HD in the resting condition, a 17% decrease at 25 W, and a 41% decrease at 50 W work load. The simulations of co-exposure in different exposure patterns with the same time-weighted concentration (TWA) of 50 ppm, i.e. 50 ppm for 8 h, 100 ppm of 4 times for 1 h and 200 ppm of twice for 1 h, showed reductions in urinary 2,5-HD of 17%, 40% and 67%, respectively. These simulations suggest that coexposure to n-hexane and toluene around 50 ppm (TWA) could affect urinary n-hexane metabolites to various degrees depending on the fluctuations in exposure concentrations and variety of work activities in the workplace. (J Occup Health 1998; 40: 293-301) Multiple exposure to solvents is often observed in workplaces 1, 2) . Toxicokinetic interactions following multiple exposure to solvents have been studied in animals as well as in humans, volunteers and occupationally exposed subjects [3] [4] [5] [6] . Due to toxicokinetic interactions, the behaviour of the biological exposure indicators used to assess the degrees of exposure may vary significantly in relation to working conditions 7, 8) . n-Hexane and toluene are common solvents in workplaces 9, 10) . Both are metabolized by the cytochrome P450 system, mainly in the liver [11] [12] [13] . In animal experiments, Iwata et al. 3, 4) showed that simultaneous inhalation of 500 ppm n-hexane and 500 ppm toluene decreased the urinary excretion of n-hexane metabolites. The exposure levels play a major role in influencing the magnitude of the metabolic interference. In a study on the interactions between toluene and benzene in which a multi-compartmental toxicokinetic simulation model was applied to a "standard male worker", Sato 14) concluded that at low exposure concentrations of benzene and toluene each solvent slightly inhibits the metabolism of the other. It is frequently argued that whenever multiple exposure in the workplace is within the occupational exposure limit values, interactions rarely occur, and that in these situations the levels of the biological indicators therefore do not undergo any particular changes compared to exposure to single substances, but several reports are in conflict with these arguments [15] [16] [17] . Little is known with hydroxylation of n-hexane to hexanols, whereas the second step is assigned to the further metabolism of hexanols to 2,5-hexanedione (2,5-HD) and other metabolites. All metabolism and metabolic interactions were assumed to take place exclusively in the liver. The metabolisms of n-hexane to hexanols and of toluene to various metabolites were described by Michaelis-Menten kinetics. Mass balance was performed on each compartment, and the transfer of solvent throughout the system was expressed in the form of the simultaneous differential equations given in Table 1 . This model is based on the assumptions that the solvent immediately Tissue/blood partition coefficient; Q: blood flow rate in L/min; subscripts alv and inh stand for alveolar air and inhaled air, respectively; c for cardiac output, l for lung, r for VRC, p for VPC, f for FC, h for liver, v for venous, art for arterial, hx for n-hexane, tol for toluene and 2,5-HD for 2,5-hexanedione. υ hl is the conversion rate of n-hexane to hexanols. K 1 and K 2 represent the conversion of hexanols to 2,5-HD and other metabolites, respectively. K 3 describes the transfer of 2,5-HD to the water compartment and K 4 is the urinary excretion constant.
respect to the degree to which mutual interaction affects the toxicokinetic behavior of the n-hexane and toluene, especially in occupationally relevant exposure conditions. P h y s i o l o g i c a l l y b a s e d pharmacokinetic (PBPK) modeling has been used to study the extrapolation of biological data from animals to humans, variability of biological exposure indicators as well as the metabolic interactions between ethanol and trichloroethylene 18) , toluene and mxylene 19) , 1,3-butadiene and styrene 20) , and ethanol and 2-butoxyethanol 21) . As an effort to evaluate the effect of dosedependent metabolic interaction between toluene and n-hexane, especially in occupationally relevant exposure conditions such as relevant exposure levels, and physical activities and exposure patterns, a physiologically based pharmacokinetic (PBPK) model for the co-exposure to n-hexane and toluene was developed.
Methods

Simulation Model
The pharmacokinetic simulation models for n-hexane and toluene were modified from Perbellini et al. 22, 23) , and Ramsey and Anderson 24) . Each model is composed of five physiological compartments, as depicted in Fig. 1 , including a lung compartment (LC), a vessel rich compartment (VRC), a vessel poor compartment (VPC), a fat tissue compartment (FC), and a liver tissue compartment (Liver). According to the studies on the metabolism of nhexane 11, 13) , the metabolic pathway of n-hexane can be expressed briefly in two steps (Fig. 1) . The first step is the reaches a balance between alveolar air and arterial blood, and that the solvent in venous blood is in dynamic equilibrium with the corresponding tissue.
Model Parameters
Model parameters are listed in Table 2 . Values for the volume and blood flow in individual compartments were assigned according to literature data 21, 25) . The blood: air and tissue: blood coefficients of n-hexane were taken from Perbellini et al. 26) , and the blood: air coefficient of toluene for humans was from Fiserova-Bergerova 27) . The human tissue: blood coefficients were assumed to be the same as those of rats and shown by Gargas et al. 28) Values for maximum metabolic rate (V max ) and Michaelis's constant (K m ) for n-hexane were taken from Perbellini et al. 23) The V max value for toluene was scaled from animal experiments according to the formula 4.8 · (weight) 0.75 for humans, whereas K m was assumed to be the same across species 19) . The conversion of hexanols to 2,5-HD and to other metabolites is defined by the rate constants K 1 and K 2 , respectively. The rate constant K 3 describes the transfer of 2,5-HD to the water compartment and K 4 is the urinary excretion rate constant. Urinary metabolites account for about 15% of the n-hexane absorbed via Table 1 . Mass balance differential equations for n-hexane in the PBPK model. Corresponding equations for toluene can be obtained from equations 1-5.
n-Hexane in storage compartments
Conversion of n-hexane to hexanols in liver compartment
2,5-Hexanedione in water compartment dA w, hd /dt = K 3 · A h, hd -K 4 · A w, hd (7) 2,5-Hexanedione in urine dA u, hd /dt = K 4 · A w, hd (
Variables A: amount; V: volume of compartment in l. Subscripts b: blood/air; i: compartments r, f and p; u: urine; w: water compartment, Other symbols are explained in Fig. 1 . inhalation 29) . The average excretion of 2,5-HD in workers exposed to 100 ppm n-hexane for 8 h was found to be 2.8 mg in 24 h 30) . The estimated uptake of n-hexane by the workers exposed to 100 ppm for 8 h is about 338 mg, assuming an alveolar ventilation of 10 l/min, and an alveolar retention of 20% 31) , so that about 0.83% of absorbed n-hexane can be expected to be excreted as 2,5-HD, corresponding to about 5.5% of urinary n-hexane metabolites. Therefore, the value for K 1 /(K 1 + K 2 ) was set at 0.055.
Modeling of metabolic interaction
Noncompetitive metabolic interaction between nhexane and toluene was assumed in view of the findings of Perbellini et al. 6) It was further assumed that n-hexane and toluene mutually interfered with each other in metabolism and that toluene affects the first step in nhexane metabolism. The above assumptions enabled us to express the rate of n-hexane metabolism under the influence of simultaneous exposure to toluene by means of the equation
where V max and K m stand for the metabolic constants of n-hexane, C h, hx , C h, tol the hepatic concentrations of nhexane and toluene, respectively, and K i, tol the n-hexane inhibitory constant of toluene. A similar equation may be used for the metabolism of toluene under the influence of n-hexane. The complete differential equations for the liver compartment are given in Table 1 . Solutions to the sets of simultaneous differential rate equations were obtained by numeral integration with a spread sheet macro written in Microsoft Excel (version 5.0) 32) .
Results
Validation of PBPK model
The behavior of venous blood concentrations of nhexane during and after human exposure to 100 ppm (360 mg/m 3 ) or 200 ppm (720 mg/m 3 ) for 4 h in the resting condition with average lung ventilation of 10.4 l/min reported by Veulemans et al. 33) were well simulated in our PBPK model for n-hexane (Fig. 2) . Furthermore, the calculated venous blood concentration and alveolar air concentration of toluene during and after 120 min exposure to 300 mg/m 3 (≅80 ppm) at rest or with a 50 W work load were in general agreement with the experimental data reported by Carlsson 34) (Fig. 3) , so it appears that our model is suitable for simulating the behavior of n-hexane and toluene in human single exposure.
Influence of toluene on n-hexane toxicokinetics
The effects of toluene + n-hexane co-exposure on nhexane levels in venous blood were simulated in a standard man who inhaled either 50 ppm (A) or 500 ppm (B) n-hexane together with 0, 25, 50, 100, or 500 ppm toluene during very light physical exercise (25 W) for 8 h a day. The results are shown in Fig. 4 . At 50 ppm nhexane alone, the concentration in blood reached nearly 0.09 mg/l at the end of the workshift without any notable changes during one week of exposure (Fig. 4A) . Coexposure to 25 ppm toluene gave only a 4% increase in blood n-hexane levels, whereas 50, 100 and 500 ppm toluene caused marked increases in blood n-hexane by 10%, 25% and 30%, respectively. At the 500 ppm nhexane level, co-exposure to 25, 50, 100 and 500 ppm toluene caused blood n-hexane increases by 6%, 7%, 8% and 8%, respectively, as compared with single exposure (Fig. 4B) . Simulated patterns of the urinary concentrations of 2,5-HD are shown in Fig. 5 . According to our model, urinary 2,5-HD reached a maximum of about 1.8 mg/l after 8 h exposure on the first day. At repeated daily 8-h exposure, 2,5-HD in urine increased gradually to a maximum of about 2.8 mg/l on the fifth day. Upon co-exposure to 50 ppm n-hexane and 25 ppm toluene, there was a 7% decrease in urinary 2,5-HD, but co-exposure to 50 or 100 ppm toluene reduced urinary 2,5-HD by 18% and 62% and 500 ppm toluene almost completely depressed it (96%) (Fig. 5A) . The corresponding reductions in urinary 2,5-HD at 500 ppm n-hexane were 18%, 37%, 70% and 95% (Fig. 5B) .
The simulated results of the effects of toluene on urinary 2,5-HD at different work loads are shown in Fig.  6 . A standard man (70 kg) inhaled 50 ppm n-hexane with 0 or 50 ppm toluene for 8 h at 0, 25 or 50 W work load. The percentages of reduction in urinary 2,5-HD were considerably different, so that there were 8%, 17% and 41% reductions under 0, 25 and 50 W work load conditions, respectively, as compared with exposure to n-hexane only.
The effect of different patterns of co-exposure to toluene and n-hexane on n-hexane metabolites in the urine was studied by simulating a standard man (70 kg) inhaling 50 ppm n-hexane together with 0 or 50 ppm toluene, expressed as time-weighted averages for 8 h at a 25 W work load. The exposure patterns were: (A) continuous co-exposure to 50 ppm n-hexane and 50 ppm toluene for 8 h, (B) four 1-h co-exposures to 100 ppm n-hexane and 100 ppm toluene during the day, and (C) two 1-h coexposures to 200 ppm n-hexane and 200 ppm toluene. The results showed that urinary excretions of 2,5-HD were remarkably different for the different exposure patterns. There were 17%, 40% and 67% decreases in urinary 2,5-HD in patterns A, B and C respectively, as compared to n-hexane alone (Fig. 7) .
Influence of n-hexane on toluene toxicokinetics
Changes in the toluene concentration in mixed venous blood after co-exposure to toluene and n-hexane are shown in Fig. 8 . Toluene in blood increased in a nonlinear fashion upon co-exposure to toluene and n-hexane, so that 50 ppm toluene plus 25 and 50 ppm n-hexane caused 2% and 6% increases in blood toluene. Coexposure to100 and 500 ppm n-hexane, on the other hand, caused relative high increases in toluene in blood of 22% and 124%, respectively (Fig. 8A) . Co-exposure to 500 ppm toluene and n-hexane (25, 50, 100, 500 ppm) induced less dramatic increases in toluene in blood (2%, 4%, 6% and 11%) (Fig. 8B) . 
Discussion
The PBPK model for n-hexane was modified from the one presented by Perbellini 22) , and the results for simulation of the kinetics of n-hexane and 2,5-HD were similar to those already reported 22, 23) . In addition, the present model for toluene, which was scaled from a rat model, seems suitable to describe the toxicokinetics of toluene, as suggested by comparing computer simulations with human volunteer experimental data 34) . There are few experimental observations as to whether co-exposure to toluene and n-hexane has any significant effect on the n-hexane concentration in human blood or urinary 2,5-HD. A field survey by Saito and Shibata 35) indicated a slight decrease in urinary 2,5-HD in workers simultaneously exposed to n-hexane and toluene at levels as low as 10-40 ppm (TWA). Cardona et al. also observed a tendency to a decrease in urinary 2,5-HD in workplaces 36) . Baelum 15) et al. reported their recent study on the mutual metabolic interaction between toluene, trichloroethylene and n-hexane. Eight health male volunteers were exposed to combinations of toluene (1.5 or 4 mg/min), trichloroethylene (1.5 or 4 mg/min) and nhexane (0.3 or 1.0 mg/min) for 60 min. The effects of the above dose rates to the liver are comparable with those obtained by inhalation of concentrations at the actual Danish occupational exposure limits (50 ppm for toluene, 30 ppm for trichloroethylene and 50 ppm for nhexane).There was no effect of either toluene or trichloroethylene co-exposure on the excretion of 2,5-HD during a 240 min period after co-exposure, but coexposure to n-hexane and toluene at a high rate decreased the hippuric acid excretion by 18%. The extent of hepatic metabolism of solvents in vivo during combined exposure is determined by the relation between the intrinsic metabolic clearances (CLi) (In the case of noncompetitive inhibition, CLi=(V max /((K m + C h, a ) (1 + C h, b /k i )), where C h, a , and C h, b are the hepatic concentrations of substances A and B, respectively) and the hepatic blood flow 37) . When CLi is much larger than hepatic blood flow, the blood flow rate limits the metabolism. Conversely, when CLi is considerably smaller than hepatic blood flow, the enzyme capacity becomes the rate limiting factor. The liver has a high capacity for metabolism of many organic solvents. Thus, at low exposure levels, blood flow limits the metabolism and metabolic interactions will not modify the overall clearance, neither the toxicokinetics or biological exposure indicators, to any significant extent. At high exposure levels, on the other hand, where metabolism approaches saturation, enzyme capacity becomes rate limiting, and interactions will affect the overall clearance more clearly. This suggests that there is a "threshold" level below which metabolic interaction is negligible. Obviously, it is of importance to identify such "thresholds" in the interpretation of biological monitoring data. Thus, for example, in controlled laboratory studies in volunteers Tardif et al. 8) observed a slowdown in toluene metabolism manifested by an increased concentration of toluene in blood and reduced urinary excretion of hippuric acid during 4 h co-exposure to 95 ppm toluene and 80 ppm xylene, but no changes in urinary metabolites were seen during 7 h exposure to 50 ppm toluene and 40 ppm xylene.
The present PBPK simulations suggested that during combined exposure to 50 ppm n-hexane and 25 ppm toluene, the rate limiting step of metabolism is liver blood flow rather than intrinsic metabolic capacity. The effects of metabolic interactions on urinary 2,5-HD might be under the intra-or extra-individual variations, and therefore their interactions were hardly detected in experiments or field studies. Nevertheless, during coexposure to 50 ppm n-hexane and 50 ppm toluene the intrinsic metabolic capacity became critical, and the effects of metabolic interactions on urinary 2,5-HD could not be neglected, but there are still other factors affecting the degree of metabolic interaction during n-hexane and toluene co-exposure. Physical activity results in dramatic changes in alveolar ventilation, cardiac output and distribution of arterial blood, thus causing profound changes in the absorption and distribution of solvents. Our PBPK model therefore suggested that the metabolic interactions between 50 ppm n-hexane and 50 ppm toluene were not so dramatic in the resting condition, but became noticeable as work intensity increased. In addition, there are great fluctuations in exposure levels in workplaces. Our simulations with different exposure patterns suggest that the urinary excretion of 2,5-HD decreases noticeably by about 67% after two 1-h coexposure to 200 ppm n-hexane and 200 ppm toluene but only marginally (17%) at continuous 50 ppm co-exposure for 8 h. Considering great fluctuations in exposure concentrations and a variety of work activities in actual workplaces, co-exposure to n-hexane and toluene could reduce urinary 2,5-HD even at concentrations lower than occupational exposure limits. These factors should be considered when the binary metabolites are used for biological exposure indices for n-hexane and toluene under co-exposure conditions.
It should be mentioned that in our simulations inhibition constants (K i ) were derived from rat experiments in vitro. Obviously, species differences between rats and man exist. In addition, several problems still remain when trying to extrapolate results for animals to man, short term in vivo and in vitro experiments to long term exposure conditions. The simulations presented here, however, suggest that dose-dependent interactions of n-hexane and toluene could occur in occupationally relevant exposure conditions. Such knowledge is valuable for biological monitoring as well as for risk assessment in combined exposure to n-hexane and toluene.
